Who Owns INHIBIKASE THERAPEUTICS INC (IKT)? -- Institutional Holders (2026-06-30)

117 institutions reported holding $239.8M of INHIBIKASE THERAPEUTICS INC (IKT) in SEC 13F filings for 2026-06-30. Largest institutional holders: Sands Capital Alternatives, LLC ($26.4M), Soleus Capital Management, L.P. ($22.1M), Trails Edge Capital Partners, LP ($18.4M), Fairmount Funds Management LLC ($17.5M), BlackRock, Inc. ($15.8M). Source: SEC Form 13F.

Rank	Institution	Value	Shares	Change
1	Sands Capital Alternatives, LLC	$26.4M	13.0M	Hold
2	Soleus Capital Management, L.P.	$22.1M	10.9M	Hold
3	Trails Edge Capital Partners, LP	$18.4M	9.1M	Added
4	Fairmount Funds Management LLC	$17.5M	8.6M	Hold
5	BlackRock, Inc.	$15.8M	7.8M	Added
6	ADAR1 Capital Management, LLC	$15.0M	7.4M	Added
7	VANGUARD GROUP INC	$13.0M	6.4M	Added
8	Blackstone Inc.	$12.1M	5.9M	Hold
9	Siren, L.L.C.	$11.9M	5.8M	Hold
10	Commodore Capital LP	$11.0M	5.4M	Hold
11	MILLENNIUM MANAGEMENT LLC	$8.2M	4.0M	Added
12	Saturn V Capital Management LP	$7.9M	3.9M	Added
13	Kalehua Capital Management LLC	$7.8M	3.8M	Trimmed
14	Spruce Street Capital LP	$7.3M	3.6M	Hold
15	Squadron Capital Management LLC	$6.1M	3.0M	Trimmed
16	Nantahala Capital Management, LLC	$5.5M	2.7M	Hold
17	GEODE CAPITAL MANAGEMENT, LLC	$5.3M	2.6M	Added
18	STATE STREET CORP	$3.9M	1.9M	Added
19	SummitTX Capital, L.P.	$3.6M	1.8M	Added
20	Integral Health Asset Management, LLC	$2.7M	1.4M	Hold
21	NORTHERN TRUST CORP	$1.8M	878,585	Added
22	TWO SIGMA INVESTMENTS, LP	$1.6M	806,264	Trimmed
23	SPHERA FUNDS MANAGEMENT LTD.	$1.3M	649,309	New
24	Kennondale Capital Management LLC	$1.1M	565,983	New
25	Pathstone Holdings, LLC	$1.0M	510,596	New

Source: SEC Form 13F filings · as of 2026-06-30